- Home
- HDRN vs ABOS Comparison
HDRN vs ABOS Comparison
Compare HDRN & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$2.70
Company Overview
Basic Information| Metric | HDRN | ABOS |
|---|---|---|
| Founded | N/A | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 193.8M | 197.9M |
| IPO Year | 2024 | 2021 |
Fundamental Metrics
Financial Performance| Metric | HDRN | ABOS |
|---|---|---|
| Price | $1.88 | $2.70 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 73.1K | ★ 684.1K |
| Earning Date | N/A | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.71 | $1.19 |
| 52 Week High | $2.63 | $3.60 |
Technical Indicators
Market Signals| Indicator | HDRN | ABOS |
|---|---|---|
| Relative Strength Index (RSI) | 31.15 | 57.94 |
| Support Level | $1.71 | $2.18 |
| Resistance Level | $2.34 | $2.76 |
| Average True Range (ATR) | 0.25 | 0.18 |
| MACD | -0.02 | 0.04 |
| Stochastic Oscillator | 18.57 | 79.38 |
Price Performance
Historical Comparison HDRN
ABOS
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.